Rajiv Khanna
@rajivkhanna62.bsky.social
Sharing our paper in @natureportfolio.nature.com bit.ly/49gaDsq We report a novel framework for off-the-shelf T cell therapy development, manufacturing, and clinical risk reduction.
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
January 12, 2026 at 10:08 AM
Sharing our paper in @natureportfolio.nature.com bit.ly/49gaDsq We report a novel framework for off-the-shelf T cell therapy development, manufacturing, and clinical risk reduction.
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
Sharing this comprehensive review on Adoptive T-cell therapy for virus-associated diseases | Clinical Microbiology Reviews journals.asm.org/doi/10.1128/... @qimrb.bsky.social @asm.org @erictopol.bsky.social
September 25, 2025 at 5:57 AM
Sharing this comprehensive review on Adoptive T-cell therapy for virus-associated diseases | Clinical Microbiology Reviews journals.asm.org/doi/10.1128/... @qimrb.bsky.social @asm.org @erictopol.bsky.social
Reposted by Rajiv Khanna
Data standards for single‐cell RNA‐sequencing of paediatric cancer - Xu - 2025 - Clinical & Translational Immunology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
<em>Clinical & Translational Immunology</em> | ASI Journal | Wiley Online Library
Publicly available scRNA-seq data can support new research ideas, especially in resource-limited settings, but the lack of standards complicates data validation and analysis. In this article, we revi....
onlinelibrary.wiley.com
May 23, 2025 at 9:29 PM
Data standards for single‐cell RNA‐sequencing of paediatric cancer - Xu - 2025 - Clinical & Translational Immunology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
🎤 Announcement
We’re excited to welcome Nirali Shah to #APVIC2025 in Brisbane.🌏✨ A leader in Pediatric Oncology, Nirali will share cutting-edge insights that will shape the future of vaccines & immunology.
📅 Don’t miss out—register now! 👉 apvic.org
We’re excited to welcome Nirali Shah to #APVIC2025 in Brisbane.🌏✨ A leader in Pediatric Oncology, Nirali will share cutting-edge insights that will shape the future of vaccines & immunology.
📅 Don’t miss out—register now! 👉 apvic.org
April 11, 2025 at 7:15 AM
🎤 Announcement
We’re excited to welcome Nirali Shah to #APVIC2025 in Brisbane.🌏✨ A leader in Pediatric Oncology, Nirali will share cutting-edge insights that will shape the future of vaccines & immunology.
📅 Don’t miss out—register now! 👉 apvic.org
We’re excited to welcome Nirali Shah to #APVIC2025 in Brisbane.🌏✨ A leader in Pediatric Oncology, Nirali will share cutting-edge insights that will shape the future of vaccines & immunology.
📅 Don’t miss out—register now! 👉 apvic.org
🚀Speaker Alert! 🚀
We’re excited to have John Anderson join us in Brisbane this May! John is from University College London and will deliver key insights that drive innovation in vaccines & immunology.
Be part of the conversation! 🌍 Register today 👉 apvic.org
We’re excited to have John Anderson join us in Brisbane this May! John is from University College London and will deliver key insights that drive innovation in vaccines & immunology.
Be part of the conversation! 🌍 Register today 👉 apvic.org
April 11, 2025 at 7:13 AM
🚀Speaker Alert! 🚀
We’re excited to have John Anderson join us in Brisbane this May! John is from University College London and will deliver key insights that drive innovation in vaccines & immunology.
Be part of the conversation! 🌍 Register today 👉 apvic.org
We’re excited to have John Anderson join us in Brisbane this May! John is from University College London and will deliver key insights that drive innovation in vaccines & immunology.
Be part of the conversation! 🌍 Register today 👉 apvic.org
Introducing APVIC 2025 Speaker
Join us in Brisbane, 20-22 May 2025, as Michelle Linterman from Malaghan Institute shares her expertise. Don’t miss this opportunity to gain cutting-edge insights from a leader in vaccines & immunology!
Register today 👉apvic.org
Join us in Brisbane, 20-22 May 2025, as Michelle Linterman from Malaghan Institute shares her expertise. Don’t miss this opportunity to gain cutting-edge insights from a leader in vaccines & immunology!
Register today 👉apvic.org
April 11, 2025 at 7:12 AM
Introducing APVIC 2025 Speaker
Join us in Brisbane, 20-22 May 2025, as Michelle Linterman from Malaghan Institute shares her expertise. Don’t miss this opportunity to gain cutting-edge insights from a leader in vaccines & immunology!
Register today 👉apvic.org
Join us in Brisbane, 20-22 May 2025, as Michelle Linterman from Malaghan Institute shares her expertise. Don’t miss this opportunity to gain cutting-edge insights from a leader in vaccines & immunology!
Register today 👉apvic.org
Sharing a video summary of our paper published in @naturecomms.bsky.social demonstrating how cellular immunotherapy developed by our team is saving lives of immunocompromised patients. shorturl.at/KMqyH
youtu.be/AXhRmDPSbR8 @qimrb.bsky.social @natureportfolio.bsky.social
youtu.be/AXhRmDPSbR8 @qimrb.bsky.social @natureportfolio.bsky.social
Cell therapy saving lives of immunocompromised patients
YouTube video by QIMR Berghofer Medical Research Institute
youtu.be
December 7, 2024 at 8:05 AM
Sharing a video summary of our paper published in @naturecomms.bsky.social demonstrating how cellular immunotherapy developed by our team is saving lives of immunocompromised patients. shorturl.at/KMqyH
youtu.be/AXhRmDPSbR8 @qimrb.bsky.social @natureportfolio.bsky.social
youtu.be/AXhRmDPSbR8 @qimrb.bsky.social @natureportfolio.bsky.social
Sharing our publication "Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years" in @NatureComms www.nature.com/articles/s41... Amazing collaboration with 20 clinical centers in Australia. @QIMRB_Institute @LSQld @qldhealth @PeterMacCC @PerthChildrens
December 6, 2024 at 9:49 PM
Sharing our publication "Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years" in @NatureComms www.nature.com/articles/s41... Amazing collaboration with 20 clinical centers in Australia. @QIMRB_Institute @LSQld @qldhealth @PeterMacCC @PerthChildrens
December 6, 2024 at 7:27 AM
Sharing our publication "Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years" in @NatureComms www.nature.com/articles/s41... Amazing collaboration with 20 clinical centers in Australia. @QIMRB_Institute @LSQld @qldhealth @PeterMacCC @PerthChildrens
December 4, 2024 at 6:27 AM
Sharing our publication "Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years" in @NatureComms www.nature.com/articles/s41... Amazing collaboration with 20 clinical centers in Australia. @QIMRB_Institute @LSQld @qldhealth @PeterMacCC @PerthChildrens
We are excited to share our publication entitled "Autologous Epstein–Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis" published in Clinical & Translational Immunology journal. onlinelibrary.wiley.com/doi/full/10....
@qimrb.bsky.social @lupus.org
@qimrb.bsky.social @lupus.org
November 30, 2024 at 11:10 PM
We are excited to share our publication entitled "Autologous Epstein–Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis" published in Clinical & Translational Immunology journal. onlinelibrary.wiley.com/doi/full/10....
@qimrb.bsky.social @lupus.org
@qimrb.bsky.social @lupus.org